SF
Shady Farah
Principal Investigator
Technion - Israel Institute of Technology
I'm working on
7 months ago
Biomaterials, Drug Delivery, Immunoengineering, Implantable Devices
About
Shady Farah holds an issued US patent in long‑acting local drug delivery and advances translational biomaterials to extend the life of implantable devices and biosensors. Backed by $700K funding, his work mitigates fibrosis and immune rejection in islet graft therapies.
No publications yet
This innovator hasn't added publications yet. In the meantime, you might want to explore their patents, funding, and other profile details.
Preventing rejection of different species derived, encapsulated islet grafts for T1D treatment
Juvenile Diabetes Research Foundation (JDRF)
•$700,000
•2022
https://patents.google.com/patent/US10851069B2/en
Issued
•2020
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.